2340

Jw Life Science Corp. (234080)

Market Closed
5 Jun, 06:30
KRX SM KRX SM
12,400. 00
+230
+1.89%
188.6B Market Cap
- P/E Ratio
2,000% Div Yield
50,181 Volume
0 Eps
12,170
Previous Close
Day Range
12,140 12,490
Year Range
10,000 12,680

Summary

234080 closed Thursday higher at ₩12,400, an increase of 1.89% from Wednesday's close, completing a monthly increase of 1.72% or ₩210. Over the past 12 months, 234080 stock gained 13.87%.
234080 is not paying dividends to its shareholders.
The last earnings report, released on May 15, 2025, exceeded the consensus estimates by 394.42%. On average, the company has surpassed earnings expectations by 229.51%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).
Want to track 234080 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

234080 Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.

Jw Life Science Corp. (234080) FAQ

What is the stock price today?

The current price is ₩12,400.00.

On which exchange is it traded?

Jw Life Science Corp. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 234080.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 188.6B.

Has Jw Life Science Corp. ever had a stock split?

No, there has never been a stock split.

Jw Life Science Corp. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Sungnam Cha CEO
KRX SM Exchange
KR7234080000 ISIN
KR Country
- Employees
- Last Dividend
15 May 2018 Last Split
- IPO Date

Overview

JW Lifescience Corporation operates within the healthcare sector, focusing on the development and distribution of infusion solutions both in its home country, South Korea, and internationally. The company has carved out a niche by specializing in products vital for patient care in various medical settings. Originally established in 1994 as JW Co. Ltd., it underwent a rebranding in April 2011 to become JW Lifescience Corporation, a name that reflects its dedication to life sciences and healthcare innovations. Based in Dangjin-si, South Korea, JW Lifescience has been at the forefront of producing and supplying a range of infusion solutions, catering to diverse medical needs and contributing significantly to the field of intravenous treatment.

Products and Services

  • Basic Intravenous Fluid

    This foundational product category includes fluids that are essential for restoring and maintaining the body's fluid and electrolyte balance. These solutions are composed of water, electrolytes like sodium, potassium, chloride, and bicarbonate, and sometimes glucose. They are used in a wide range of medical situations, from routine hydration to emergency resuscitation.

  • Nutrient Infusion Solution

    JW Lifescience Corporation also provides nutrient-rich infusion solutions, engineered to supply vital nutrients directly into the bloodstream. These formulations typically contain amino acids, lipids, proteins, vitamins, and minerals. They are crucial for patients who are unable to eat or digest food normally, offering a method to support their nutritional needs intravenously.

  • Special Infusion Solutions

    The company develops and distributes specialized infusion solutions designed for specific clinical scenarios. These advanced products may be tailored to support organ function, aid in surgical recovery, or treat particular diseases or disorders. They underscore JW Lifescience Corporation's commitment to innovative healthcare solutions and their ability to meet the specialized needs of patients and medical practitioners alike.

Contact Information

Address: 28, Hanjin 1-gil, Dangjin-si, South Korea, 31720
Phone: 82 4 1351 7600